Intravenous administration of human basic fibroblast growth factor (bF
GF) for 2 weeks stimulated osteoblast proliferation and new bone forma
tion in various skeletal bones in young and aged rats at dosage levels
of 0.1 mg/kg/day and greater. Morphometry of the soft X-ray radiogram
s of cross sections of the tibia indicated about a 20% increase in the
calcified bone area of the diaphysis at 0.1 mg/kg/day. The Ca and hyd
roxyproline contents showed statistically significant increases at thi
s dosage. The new bone formation was found only on the endosteal side,
and no periosteal bone formation was found. Similar systemic osteogen
ic potential was seen after intravenous administration of other growth
factors of the FGF family, human acidic FGF and human heparin-binding
secretory transforming protein-1. The above results suggest a potenti
al therapeutic role for these growth factors in bone-loss diseases suc
h as osteoporosis.